Evidence map›Paper›PMID 40808866›Full record

ArticleTherapeutic advances in gastroenterology2025

Identifying inflammatory bowel disease subtypes: a comprehensive exploration of transcriptomic data and machine learning-based approaches.

Niyati Saini, Animesh Acharjee

Abstract read
In one paragraph

Article in Therapeutic advances in gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Niyati SainiCancer and Genomic Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK.
Animesh AcharjeeCancer and Genomic Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK.ORCID https://orcid.org/0000-0003-2735-7010

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is a heterogeneous condition characterised by chronic gastrointestinal inflammation and dysregulated immune responses. Despite advances in transcriptomic analysis and machine learning (ML), consistent molecular subtyping across datasets remains a challenge. There is a critical need for robust subtypes that reflect disease heterogeneity and correlate with clinical outcomes. Objectives: Unlike prior studies focused on either UC or CD or based on small datasets, this study analyses a large-scale RNA sequencing (RNA-seq) dataset to identify transcriptomic subtypes in both UC and CD. Design: We analysed RNA-seq data from four prospective cross-sectional cohorts from Gene Expression Omnibus: GSE193677, GSE186507, GSE137344 and GSE235236. Methods: Analysed RNA-sequenced data from inflamed and non-inflamed intestinal biopsies of 2490 adult IBD patients. Results: Conclusion: We report three transcriptomic subtypes in UC and CD, each with distinct molecular signatures and clinical relevance. These findings support a stratified approach to IBD diagnosis and therapy, enabling more personalised disease management strategies.

Indexed as

Crohn’s diseaseIBD subtypesmachine learningtranscriptomicsulcerative colitis

Identifiers

PMID40808866
PMCPMC12344326

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.